{"entity":{"type":"insider","cik":"0001789857","url":"/insider/0001789857","json_url":"/insider/0001789857.json","name":"Zalevsky Jonathan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":36,"first":"2019-11-20","last":"2026-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Zalevsky Jonathan","source":"filing","n_filings":36,"first_seen":"2019-11-20","last_seen":"2026-08-20"}],"transactions":[{"id":9299460,"accession":"0001193125-26-359588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-359588","line_url":"/filing/0001193125-26-359588#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":186.0,"shares_display":"186","price_per_share":71.98,"price_display":"71.98","price_state":"stated","total_value":13388.28,"total_display":"13,388.28","total_whole":"13,388","shares_owned_after":9570.0,"shares_owned_after_display":"9,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-20","scope":"insider"},{"id":6089210,"accession":"0001193125-26-295112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-295112","line_url":"/filing/0001193125-26-295112#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5681.0,"shares_display":"5,681","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":397670.0,"total_display":"397,670.00","total_whole":"397,670","shares_owned_after":9756.0,"shares_owned_after_display":"9,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-02","scope":"insider"},{"id":5983691,"accession":"0001193125-26-274534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-274534","line_url":"/filing/0001193125-26-274534#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5538.0,"shares_display":"5,538","price_per_share":60.71,"price_display":"60.71","price_state":"stated","total_value":336211.98,"total_display":"336,211.98","total_whole":"336,212","shares_owned_after":15437.0,"shares_owned_after_display":"15,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":6177395,"accession":"0001193125-26-235030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-235030","line_url":"/filing/0001193125-26-235030#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199.0,"shares_display":"199","price_per_share":65.51,"price_display":"65.51","price_state":"stated","total_value":13036.49,"total_display":"13,036.49","total_whole":"13,036","shares_owned_after":20975.0,"shares_owned_after_display":"20,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-21","scope":"insider"},{"id":6171136,"accession":"0001193125-26-061886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-061886","line_url":"/filing/0001193125-26-061886#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":13140.0,"total_display":"13,140.00","total_whole":"13,140","shares_owned_after":21174.0,"shares_owned_after_display":"21,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":6228389,"accession":"0001193125-26-019843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-019843","line_url":"/filing/0001193125-26-019843#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3867.0,"shares_display":"3,867","price_per_share":35.67,"price_display":"35.67","price_state":"stated","total_value":137935.89,"total_display":"137,935.89","total_whole":"137,936","shares_owned_after":21354.0,"shares_owned_after_display":"21,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider"},{"id":4093444,"accession":"0001193125-25-297855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-297855","line_url":"/filing/0001193125-25-297855#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1157.0,"shares_display":"1,157","price_per_share":54.28,"price_display":"54.28","price_state":"stated","total_value":62801.96,"total_display":"62,801.96","total_whole":"62,802","shares_owned_after":18971.0,"shares_owned_after_display":"18,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":5119110,"accession":"0000950170-25-113692","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-113692","line_url":"/filing/0000950170-25-113692","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1721.0,"shares_display":"1,721","price_per_share":33.52266705403835,"price_display":"33.52","price_state":"stated","total_value":57692.51,"total_display":"57,692.51","total_whole":"57,693","shares_owned_after":18390.0,"shares_owned_after_display":"18,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider","n_lines":4},{"id":4983902,"accession":"0000950170-25-113130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113130","line_url":"/filing/0000950170-25-113130#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":485.0,"shares_display":"485","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":14598.5,"total_display":"14,598.50","total_whole":"14,599","shares_owned_after":19183.0,"shares_owned_after_display":"19,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":5159574,"accession":"0000950170-25-110775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-110775","line_url":"/filing/0000950170-25-110775#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":725.0,"shares_display":"725","price_per_share":26.59,"price_display":"26.59","price_state":"stated","total_value":19277.75,"total_display":"19,277.75","total_whole":"19,278","shares_owned_after":19668.0,"shares_owned_after_display":"19,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-21","scope":"insider"},{"id":4617905,"accession":"0000950170-25-075979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-075979","line_url":"/filing/0000950170-25-075979#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10712.0,"shares_display":"10,712","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":7177.04,"total_display":"7,177.04","total_whole":"7,177","shares_owned_after":305892.0,"shares_owned_after_display":"305,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-21","scope":"insider"},{"id":4131078,"accession":"0000950170-25-025043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-025043","line_url":"/filing/0000950170-25-025043#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10300.0,"shares_display":"10,300","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":10403.0,"total_display":"10,403.00","total_whole":"10,403","shares_owned_after":316604.0,"shares_owned_after_display":"316,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":3153063,"accession":"0000950170-24-139242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-139242","line_url":"/filing/0000950170-24-139242#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51115.0,"shares_display":"51,115","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":48048.1,"total_display":"48,048.10","total_whole":"48,048","shares_owned_after":326904.0,"shares_owned_after_display":"326,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2903312,"accession":"0000950170-24-129463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129463","line_url":"/filing/0000950170-24-129463#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7785.0,"shares_display":"7,785","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":7862.85,"total_display":"7,862.85","total_whole":"7,863","shares_owned_after":243019.0,"shares_owned_after_display":"243,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":3112201,"accession":"0000950170-24-099354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-099354","line_url":"/filing/0000950170-24-099354#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6866.0,"shares_display":"6,866","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":8788.48,"total_display":"8,788.48","total_whole":"8,788","shares_owned_after":250804.0,"shares_owned_after_display":"250,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider"},{"id":2850704,"accession":"0000950170-24-062645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-062645","line_url":"/filing/0000950170-24-062645#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7355.0,"shares_display":"7,355","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":12871.25,"total_display":"12,871.25","total_whole":"12,871","shares_owned_after":257670.0,"shares_owned_after_display":"257,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"},{"id":2893070,"accession":"0000950170-24-019045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-019045","line_url":"/filing/0000950170-24-019045#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9014.0,"shares_display":"9,014","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":6129.52,"total_display":"6,129.52","total_whole":"6,130","shares_owned_after":265025.0,"shares_owned_after_display":"265,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider"},{"id":8547821,"accession":"0001209191-23-056184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056184","line_url":"/filing/0001209191-23-056184#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9646.0,"shares_display":"9,646","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":4726.54,"total_display":"4,726.54","total_whole":"4,727","shares_owned_after":274039.0,"shares_owned_after_display":"274,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8116448,"accession":"0001209191-23-046462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046462","line_url":"/filing/0001209191-23-046462#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9703.0,"shares_display":"9,703","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":7568.34,"total_display":"7,568.34","total_whole":"7,568","shares_owned_after":283685.0,"shares_owned_after_display":"283,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":7835332,"accession":"0001209191-23-030448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030448","line_url":"/filing/0001209191-23-030448#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9791.0,"shares_display":"9,791","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":7049.52,"total_display":"7,049.52","total_whole":"7,050","shares_owned_after":293388.0,"shares_owned_after_display":"293,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":7949298,"accession":"0001209191-23-010956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010956","line_url":"/filing/0001209191-23-010956#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10484.0,"shares_display":"10,484","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":31452.0,"total_display":"31,452.00","total_whole":"31,452","shares_owned_after":303179.0,"shares_owned_after_display":"303,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":6927040,"accession":"0001209191-22-057968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057968","line_url":"/filing/0001209191-22-057968#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13460.0,"shares_display":"13,460","price_per_share":3.57,"price_display":"3.57","price_state":"stated","total_value":48052.2,"total_display":"48,052.20","total_whole":"48,052","shares_owned_after":313663.0,"shares_owned_after_display":"313,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6753402,"accession":"0001209191-22-046909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-046909","line_url":"/filing/0001209191-22-046909#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73716.0,"shares_display":"73,716","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":342779.4,"total_display":"342,779.40","total_whole":"342,779","shares_owned_after":327123.0,"shares_owned_after_display":"327,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-19","scope":"insider"},{"id":6548027,"accession":"0001209191-22-046489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046489","line_url":"/filing/0001209191-22-046489#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10560.0,"shares_display":"10,560","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":50265.6,"total_display":"50,265.60","total_whole":"50,266","shares_owned_after":400839.0,"shares_owned_after_display":"400,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":6429748,"accession":"0001209191-22-029905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-029905","line_url":"/filing/0001209191-22-029905#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21673.0,"shares_display":"21,673","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":85608.35,"total_display":"85,608.35","total_whole":"85,608","shares_owned_after":276399.0,"shares_owned_after_display":"276,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":6918840,"accession":"0001209191-22-011442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011442","line_url":"/filing/0001209191-22-011442#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10912.0,"shares_display":"10,912","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":119486.4,"total_display":"119,486.40","total_whole":"119,486","shares_owned_after":274122.0,"shares_owned_after_display":"274,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":4105674,"accession":"0001209191-21-065229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065229","line_url":"/filing/0001209191-21-065229#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20869.0,"shares_display":"20,869","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":274636.04,"total_display":"274,636.04","total_whole":"274,636","shares_owned_after":232084.0,"shares_owned_after_display":"232,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider"},{"id":5381530,"accession":"0001209191-21-052395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052395","line_url":"/filing/0001209191-21-052395#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7662.0,"shares_display":"7,662","price_per_share":13.83,"price_display":"13.83","price_state":"stated","total_value":105965.46,"total_display":"105,965.46","total_whole":"105,965","shares_owned_after":212803.0,"shares_owned_after_display":"212,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4997521,"accession":"0001209191-21-034191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034191","line_url":"/filing/0001209191-21-034191#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31111.0,"shares_display":"31,111","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":569331.3,"total_display":"569,331.30","total_whole":"569,331","shares_owned_after":235065.0,"shares_owned_after_display":"235,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"},{"id":4527037,"accession":"0001209191-21-012128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012128","line_url":"/filing/0001209191-21-012128#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24141.0,"shares_display":"24,141","price_per_share":22.37,"price_display":"22.37","price_state":"stated","total_value":540034.17,"total_display":"540,034.17","total_whole":"540,034","shares_owned_after":266176.0,"shares_owned_after_display":"266,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":2346201,"accession":"0001209191-20-060584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-060584","line_url":"/filing/0001209191-20-060584#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16380.0,"shares_display":"16,380","price_per_share":16.4,"price_display":"16.40","price_state":"stated","total_value":268632.0,"total_display":"268,632.00","total_whole":"268,632","shares_owned_after":250317.0,"shares_owned_after_display":"250,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":3131862,"accession":"0001209191-20-059247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059247","line_url":"/filing/0001209191-20-059247#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29618.0,"shares_display":"29,618","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":501432.74,"total_display":"501,432.74","total_whole":"501,433","shares_owned_after":266697.0,"shares_owned_after_display":"266,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":2647515,"accession":"0001209191-20-047620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047620","line_url":"/filing/0001209191-20-047620#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26200.0,"shares_display":"26,200","price_per_share":19.67,"price_display":"19.67","price_state":"stated","total_value":515354.0,"total_display":"515,354.00","total_whole":"515,354","shares_owned_after":296315.0,"shares_owned_after_display":"296,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":2898444,"accession":"0001209191-20-031018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031018","line_url":"/filing/0001209191-20-031018#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4558.0,"shares_display":"4,558","price_per_share":22.51,"price_display":"22.51","price_state":"stated","total_value":102600.58,"total_display":"102,600.58","total_whole":"102,601","shares_owned_after":322515.0,"shares_owned_after_display":"322,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2367302,"accession":"0001209191-20-011263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-011263","line_url":"/filing/0001209191-20-011263#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4774.0,"shares_display":"4,774","price_per_share":22.35,"price_display":"22.35","price_state":"stated","total_value":106698.9,"total_display":"106,698.90","total_whole":"106,699","shares_owned_after":327073.0,"shares_owned_after_display":"327,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":8352003,"accession":"0001209191-19-057492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-057492","line_url":"/filing/0001209191-19-057492#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001789857","owner_name":"Zalevsky Jonathan","owner_display_name":"Zalevsky Jonathan","owner_url":"/insider/0001789857","role":"Officer (Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3960.0,"shares_display":"3,960","price_per_share":17.97,"price_display":"17.97","price_state":"stated","total_value":71161.2,"total_display":"71,161.20","total_whole":"71,161","shares_owned_after":291697.0,"shares_owned_after_display":"291,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Officer (Chief R&D Officer)","n_filings":36,"first_seen":"2019-11-20","last_seen":"2026-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789857","retrieved_at":"2026-08-25T22:13:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}